Edward Piper

1.1k citations

14 papers · 885 indexed · h-index 8

Impact in

Immunology and Allergy top 2%
- Allergic Rhinitis and Sensitization
Physiology top 5%
- Asthma and respiratory diseases

Papers in ⓘ

Physiology 10
- Asthma and respiratory diseases 10
Pulmonary and Respiratory Medicine 8
- Respiratory and Cough-Related Research 6
- Inhalation and Respiratory Drug Delivery 5

Co-authors: Christopher E. Brightling (7 shared papers)Dewei She (9 shared papers)Richard May (3 shared papers)Paul M. O’Byrne (1 shared paper)Katie Streicher (2 shared papers)Raffaella Faggioni (3 shared papers)Néstor A. Molfino (3 shared papers)Pascal Chanez (1 shared paper)
Journals: European Respiratory Journal (2 papers)The Lancet Respiratory Medicine (2 papers)Drug Metabolism and Pharmacokinetics (1 paper)British Journal of Clinical Pharmacology (1 paper)Gut (1 paper)
Partner nations: United Kingdom United States Sweden

In The Last Decade

Edward Piper

12 papers receiving 851 citations

Peers

Countries citing papers authored by Edward Piper

Since Specialization

Citations

This map shows the geographic impact of Edward Piper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Piper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Piper more than expected).

Fields of papers citing papers by Edward Piper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Piper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Piper. The network helps show where Edward Piper may publish in the future.

Co-authors

The 25 scholars most cited alongside Edward Piper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Edward Piper Line = papers co-authored together Edward Piper links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work
1	A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma European Respiratory Journal ·Edward Piper, Christopher E. Brightling, Robert Niven, Chad K. Oh, Raffaella Faggioni, Kwai Poon, Dewei She, Chris Kell, Richard May, Gregory P. Geba, Néstor A. Molfino	2012	290
2	Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial The Lancet Respiratory Medicine ·Christopher E. Brightling, Pascal Chanez, Richard Leigh, Paul M. O’Byrne, Stephanie Korn, Dewei She, Richard May, Katie Streicher, Koustubh Ranade, Edward Piper	2015	285
3	Tralokinumab for severe, uncontrolled asthma (STRATOS 1 and STRATOS 2): two randomised, double-blind, placebo-controlled, phase 3 clinical trials The Lancet Respiratory Medicine ·Reynold A. Panettieri, Ulf Sjöbring, AnnaMaria Péterffy, Peter Wessman, Karin Bowen, Edward Piper, Gene Colice, Christopher E. Brightling	2018	177
4	Lapaquistat Acetate Circulation ·Evan A. Stein, Harold Bays, Dennis O’Brien, J Pedicano, Edward Piper, Andrea Spezzi	2011	54
5	Pharmacokinetics of tralokinumab in adolescents with asthma: implications for future dosing British Journal of Clinical Pharmacology ·Paul Baverel, Meena Jain, Iwona Stelmach, Dewei She, Balaji Agoram, Sara Sandbach, Edward Piper, Piotr Kuna	2015	23
6	Computer analysis of intraluminal pressure records. Gut ·J J Misiewicz, S. L. Waller, M. J. R. Healy, Edward Piper	1968	17
7	A randomized, placebo-controlled, single ascending-dose study to assess the safety, tolerability, pharmacokinetics, and immunogenicity of subcutaneous tralokinumab in Japanese healthy volunteers Drug Metabolism and Pharmacokinetics ·Paul Baverel, Dewei She, Edward Piper, Shinya Ueda, Tomoko Yoshioka, Raffaella Faggioni, Hakop Gevorkyan	2017	15
8	Effect of Anti–IL-13 Treatment on Airway Dimensions in Severe Asthma American Journal of Respiratory and Critical Care Medicine ·Christopher E. Brightling, Lars H. Nordenmark, Meena Jain, Edward Piper, Dewei She, Martin Braddock, Gene Colice, Göran Tornling	2016	10
9	Phase 2 randomized, double-blind, placebo-controlled study of tralokinumab, an anti-IL-13 monoclonal antibody, in moderate to severe asthma European Respiratory Journal ·Edward Piper, Christopher E. Brightling, Robert Niven, Chad K. Oh, Raffaella Faggioni, Kwai Poon, Dewei She, Chris Kell, Richard May, Gregory P. Geba, Néstor A. Molfino	2011	7
10	Subgroup Analysis Of A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study Of Tralokinumab, An Anti-IL-13 Monoclonal Antibody, In Moderate To Severe Asthma Edward Piper, Dewei She, Néstor A. Molfino	2012	5
11	Effect of tralokinumab on GINA control in severe, uncontrolled asthma Christopher E. Brightling, Edward Piper, Peter Wessman, Gene Colice	2017	1
12	Dipeptidyl peptidase-4 (DPP-4) may predict response to tralokinumab in patients with asthma Koustubh Ranade, Michael Kuziora, Tuyet‐Hang Pham, Gautam Damera, Philip Z. Brohawn, Fernanda Pilataxi, Katie Streicher, Scott Martinez, Inna Vainshtein, Meina Liang, Dewei She, Edward Piper, Chrisopher E. Brightling, Richard J. Martin	2016	1
13	Effect of anti-IL-13 treatment on airway dimensions in severe asthma: Subgroup analysis Christopher E. Brightling, Lars H. Nordenmark, Meena Jain, Edward Piper, Dewei She, Martin Braddock, Gene Colice, Göran Tornling	2015	0
14	Computer analysis ofintraluminal pressure records J J Misiewicz, S. L. Waller, M. J. R. Healy, Edward Piper	1968	0

About Edward Piper

Edward Piper is a scholar working on Physiology, Pulmonary and Respiratory Medicine, Infectious Diseases, Surgery and Pediatrics, Perinatology and Child Health, having authored 14 papers that have together received 885 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (10 papers), Respiratory and Cough-Related Research (6 papers), Inhalation and Respiratory Drug Delivery (5 papers), Antifungal resistance and susceptibility (2 papers), Pharmaceutical studies and practices (2 papers), Atherosclerosis and Cardiovascular Diseases (1 paper), Peptidase Inhibition and Analysis (1 paper) and Allergic Rhinitis and Sensitization (1 paper). The work is most often cited by research in Immunology and Allergy (213 citations), Physiology (691 citations), Immunology (326 citations), Pulmonary and Respiratory Medicine (404 citations) and Dermatology (105 citations). Edward Piper has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Christopher E. Brightling, Dewei She, Richard May, Paul M. O’Byrne, Katie Streicher, Raffaella Faggioni, Néstor A. Molfino, Pascal Chanez, Stephanie Korn and Richard Leigh. Their work appears in journals such as European Respiratory Journal, The Lancet Respiratory Medicine, Drug Metabolism and Pharmacokinetics, British Journal of Clinical Pharmacology and Gut.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact